|
|
cell adhesion
|
GO:0007155 |
329 |
0.656
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.607
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.590
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.574
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.568
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.551
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.549
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.517
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.510
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.505
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.474
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.447
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.446
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.434
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.428
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.421
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.420
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.418
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.417
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.393
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.381
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.377
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.374
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.369
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.367
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.365
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.362
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.361
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.357
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.355
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.349
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.341
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.332
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.331
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.326
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.325
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.319
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.315
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.314
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.314
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.313
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.312
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.305
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.296
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.296
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.294
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.285
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.278
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.268
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.266
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.262
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.244
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.240
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.240
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.239
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.228
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.224
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.223
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.215
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.212
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.210
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.209
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.207
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.203
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.201
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.197
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.193
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.185
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.184
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.184
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.182
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.177
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.176
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.164
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.160
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.156
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.156
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.155
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.155
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.148
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.140
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.138
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.131
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.130
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.124
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.119
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.117
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.114
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.114
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.113
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.108
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.102
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.102
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.096
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.096
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.091
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.091
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.090
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.090
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.090
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.090
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.090
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.089
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.088
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.086
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.086
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.084
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.084
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.084
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.083
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.083
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.081
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.080
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.079
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.077
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.077
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.077
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.074
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.074
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.073
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.073
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.073
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.072
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.072
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.071
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.070
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.069
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.069
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.069
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.068
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.068
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.067
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.066
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.066
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.066
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.066
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.065
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.065
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.065
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.065
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.065
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.064
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.064
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.063
|
|
|
|
left right pattern formation
|
GO:0060972 |
23 |
0.063
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.063
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.062
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.062
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.062
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.061
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.061
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.061
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.061
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.060
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.060
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.060
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.060
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.058
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.057
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.057
|
|
|
|
intraciliary retrograde transport
|
GO:0035721 |
3 |
0.057
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.056
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.055
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.055
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.054
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.054
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.054
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.054
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.054
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.053
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.052
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.052
|
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
20 |
0.052
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.052
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.052
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.051
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.051
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.051
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.050
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.050
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.050
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.049
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.049
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.049
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.048
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.048
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.048
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.048
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.047
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.047
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.047
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.047
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.047
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.047
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.047
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.046
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.046
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.046
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.046
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.046
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.045
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.045
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.045
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.044
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.044
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.044
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.044
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.044
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.044
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.043
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.043
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.043
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.043
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.043
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.043
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.043
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.043
|
|
|
|
positive regulation of protein acetylation
|
GO:1901985 |
9 |
0.043
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.043
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.042
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.042
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.042
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.042
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.042
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.042
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.042
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.042
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.042
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.042
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.041
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.041
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.041
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.040
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.040
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.040
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.039
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.039
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.039
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.039
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.039
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.039
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.039
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.038
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.038
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.038
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.038
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.037
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.037
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.037
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.036
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.036
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.036
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.035
|
|
|
|
osteoblast development
|
GO:0002076 |
17 |
0.035
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.035
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.035
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.035
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.035
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.035
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.035
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.035
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.035
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.035
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.035
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.035
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.035
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.035
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.034
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.034
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.034
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.034
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.034
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.033
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.033
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.033
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.033
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.033
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.033
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.033
|
|
|
|
positive regulation of histone acetylation
|
GO:0035066 |
8 |
0.032
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.032
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.032
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.032
|
|
|
|
intraciliary transport
|
GO:0042073 |
9 |
0.032
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.032
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.032
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.031
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.031
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.031
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.031
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.031
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.031
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.031
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.031
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.031
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.031
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.030
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.030
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.030
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.030
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.030
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.030
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.030
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.030
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.030
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.029
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.029
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.029
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.029
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.029
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.029
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.029
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.029
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.029
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.028
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.028
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.028
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.028
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.028
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.028
|
|
|
|
wound healing spreading of cells
|
GO:0044319 |
8 |
0.028
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.028
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.028
|
|
|
|
dendritic spine organization
|
GO:0097061 |
26 |
0.027
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.027
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.027
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.027
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.027
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.027
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.027
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.027
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.027
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.027
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.026
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.026
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.026
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.026
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.026
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.026
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.026
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.026
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.026
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.026
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.026
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.026
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.026
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.025
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.025
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.025
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.025
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.025
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.025
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.025
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.025
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.025
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.025
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.024
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.024
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.024
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.024
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.024
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.024
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.024
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.024
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.024
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.024
|
|
|
|
negative regulation of dendritic spine morphogenesis
|
GO:0061002 |
3 |
0.024
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.024
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.024
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.023
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.023
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.023
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.023
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.023
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.023
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.023
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.023
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.022
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.022
|
|
|
|
epiboly
|
GO:0090504 |
8 |
0.022
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.022
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.022
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.022
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.022
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.022
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.022
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.022
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.022
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.022
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.022
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.022
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.021
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.021
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.021
|
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.021
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.021
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.021
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.021
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.021
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.020
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.020
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.020
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.020
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.020
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.020
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.020
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.020
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.020
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.020
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.020
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.020
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.020
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.020
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.020
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.019
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.019
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.019
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.019
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.019
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.019
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.019
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.019
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.018
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.018
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.018
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.018
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.018
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.018
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.018
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.018
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.018
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.018
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.018
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.018
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.018
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.018
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.018
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.018
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.018
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.018
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.018
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.018
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.018
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.018
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.018
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.017
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.017
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.017
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.017
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.017
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.017
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.017
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.017
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.017
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.017
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.017
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.017
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.017
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.017
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.017
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.017
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.017
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.017
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.017
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.017
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.017
|
|
